Zocor Falls Off Formularies As Part D Plans Shift Patients To Generic Statins
Executive Summary
Zocor dropped quickly off of Part D formularies after having enjoyed wide preferred coverage in 2006, an analysis of 2007 Part D basic plan coverage of the statin group of cholesterol-lowering drugs indicates
You may also be interested in...
Merck Pushes Discount Zocor; Health Plans Are Wary, But Pfizer Is Concerned
The mixed response to Merck's efforts to reach rebate agreements with health plans to place brand Zocor on the lowest cost-sharing tiers of their formularies suggests it is unlikely such a strategy would be broadly adopted by brand firms going forward
Merck Wins Part D Cholesterol Therapy Formulary Battle; Lipitor In Retreat?
Merck appears to be the big winner in the Medicare Part D formulary placement battle for cholesterol-lowering therapies, according to an analysis of plan formularies conducted by the "The Pink Sheet."
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011